Neus Prats

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity”.

Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity

Neurobiology of Disease(2020)10.1016/j.nbd.2020.105173

N/A

0DataRank · unranked

31 citations

Jordi Durán, Mònica Aguilera, Neus Prats, Joan J. Guinovart, Olga Varea

The efficacy of chemotherapy is limited by intratumoural senescent cells that persist through the upregulation of PD-L2

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.04.501681

N/A

0DataRank · unranked

7 citations

José A López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Inés Marín, Kathleen Meyer +14 more

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Nature Cancer(2024)10.1038/s43018-023-00712-x

N/A

0DataRank · unranked

99 citations

José A López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Inés Marín, Olga Boix +18 more